Interventional Oncology & Embolization
Interventional Oncology & Embolization supports physicians and patients through product donations for indigent care and humanitarian missions to expand access to minimally invasive cancer care.
Browse similar grants
Funder: Boston Scientific
Due Dates: December 1, 2026 (Submission) | December 10, 2026 (Committee review)
Funding Amounts: Product donations for indigent care and humanitarian missions
Summary: Supports access to minimally invasive cancer care through TheraSphere Y-90 Glass Microspheres donations for indigent care and product donations for humanitarian missions.
Key Information: Submit requests at least two months before the event or the date a decision is needed.
Description
Boston Scientific’s Interventional Oncology & Embolization giving program provides product donations within the company’s minimally invasive cancer care business. That business includes therapies and clinically differentiated solutions intended to help physicians and patients. The support described for this program centers on access to care through donations, rather than a defined research funding agenda.
The program provides TheraSphere Y-90 Glass Microspheres for indigent care and also offers product donations for humanitarian missions. Requests are reviewed by Boston Scientific’s Interventional Oncology Grant Committee according to its scheduled submission deadlines and meeting dates.
